Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

AI-Assisted Structured Guidance for Narrative Review Writing

25. mai 2026 oppdatert av: Zhongshan Ophthalmic Center, Sun Yat-sen University

Effect of Artificial Intelligence-Assisted Structured Guidance on the Quality of Narrative Literature Reviews Among Medical Postgraduate Students: A Randomized Controlled Educational Study

This randomized, parallel-group, assessor-blinded educational study will evaluate whether one session of AI-assisted structured guidance improves the quality of narrative literature reviews written by medical postgraduate students. A total of 102 students enrolled in an academic writing course will be randomly assigned to either an AI-assisted structured guidance group or a free AI use group. Both groups may use AI tools under academic integrity requirements and will complete a narrative literature review according to the same course requirements. The guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six dimensions of the Scale for the Assessment of Narrative Review Articles (SANRA). The primary outcome is the final SANRA total score of the submitted narrative literature review.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Generative artificial intelligence is increasingly used by medical students and postgraduate trainees for literature searching, summarization, outlining, and academic writing. However, free use of AI may be associated with inaccurate information, unsupported statements, fabricated references, and inadequate academic judgment. This study is designed to evaluate whether structured guidance can improve the quality and academic integrity of AI-assisted narrative review writing.

Participants will be medical postgraduate students enrolled in an academic writing course. After informed consent and baseline data collection, participants will be randomized in a 1:1 ratio to an AI-assisted structured guidance group or a free AI use group. Both groups will complete a narrative literature review of approximately 2,000 Chinese characters according to the same course requirements and may use AI tools under academic integrity requirements.

Participants in the AI-assisted structured guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six SANRA dimensions: explanation of the importance of the article, statement of aims or questions, description of the literature search, reference support for key statements, scientific reasoning, and appropriate presentation of data and content. The instructor will provide directional and methodological feedback but will not directly write or edit the students' text line by line. Participants in the free AI use group will complete the review according to the same course requirements without the structured guidance session.

After submission, all narrative reviews will be anonymized and assessed by independent outcome assessors blinded to group allocation. The primary outcome is the final SANRA total score. Secondary outcomes include SANRA item scores, multiple-source academic writing self-efficacy, and reference authenticity error rate.

Studietype

Intervensjonell

Registrering (Antatt)

102

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

  • Kina
    • Guangdong
      • Guangzhou, Guangdong, Kina, 510060
        • Zhongshan Ophthalmic Center, Sun Yat-sen University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  1. Master's students enrolled in the Academic Standards and Thesis Writing course.
  2. Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
  3. Able to complete literature searching, use AI tools, and complete online questionnaires.

Exclusion Criteria:

  1. Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
  2. Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: AI-Assisted Structured Guidance Group
Participants in this group will complete a narrative literature review according to the same course requirements as the control group. They may use AI tools under academic integrity requirements and will additionally receive one structured guidance session approximately two weeks before final submission.
Atferdsmessig: AI-Assisted Structured Guidance
A single structured guidance session delivered approximately two weeks before final submission. The session is based on the six SANRA dimensions and provides directional and methodological feedback on narrative review writing and appropriate AI use, without direct writing or line-by-line editing of students' text.
Atferdsmessig: Free AI Use
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review. Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
Aktiv komparator: Free AI Use Group
Participants in this group will complete a narrative literature review according to the same course requirements and may use AI tools under academic integrity requirements. They will not receive the structured guidance session during the study period.
Atferdsmessig: Free AI Use
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review. Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Final SANRA Total Score
Tidsramme: Week 2
The quality of the final narrative literature review will be assessed using the Scale for the Assessment of Narrative Review Articles (SANRA). The SANRA total score ranges from 0 to 12, with higher scores indicating better quality of the narrative review.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
SANRA Item 1 Score: Importance of the Article
Tidsramme: Week 2
This outcome assesses SANRA item 1, which evaluates whether the importance of the narrative review article is adequately explained. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 2 Score: Aims or Questions
Tidsramme: Week 2
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 3 Score: Literature Search Description
Tidsramme: Week 2
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 4 Score: Referencing
Tidsramme: Week 2
At final submission of the narrative literature review; assessment completed within 4 weeks after final submission.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 5 Score: Scientific Reasoning
Tidsramme: Week 2
This outcome assesses SANRA item 5, which evaluates whether the scientific reasoning is based on appropriate evidence. The item score ranges from 0 to 2, with higher scores indicating better scientific reasoning.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
SANRA Item 6 Score: Data and Content Presentation
Tidsramme: Week 2
This outcome assesses SANRA item 6, which evaluates whether data and content are presented appropriately. The item score ranges from 0 to 2, with higher scores indicating better presentation.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2
Change From Baseline in Multiple-Source Academic Writing Self-Efficacy Score
Tidsramme: Baseline and Week 2
Multiple-source academic writing self-efficacy will be assessed using an adapted 8-item Multiple-Source Academic Writing Self-Efficacy Scale. The change from baseline to final submission will be analyzed. Higher scores indicate greater self-efficacy in integrating multiple sources for academic writing.
Baseline and Week 2
Reference Authenticity Error Rate
Tidsramme: Week 2
The proportion of references with authenticity errors will be calculated for each submitted narrative literature review. References will be verified using available bibliographic information such as DOI, PMID, title, authors, PubMed, CrossRef, Web of Science, Google Scholar, journal websites, or publisher websites. A higher error rate indicates poorer reference authenticity.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Week 2

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. juni 2026

Primær fullføring (Antatt)

1. august 2026

Studiet fullført (Antatt)

1. september 2026

Datoer for studieregistrering

Først innsendt

25. mai 2026

Først innsendt som oppfylte QC-kriteriene

25. mai 2026

Først lagt ut (Faktiske)

1. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

25. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

  • IIT2026064

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared because the study involves students' coursework, questionnaires, AI use declarations, and writing-related educational data. These data may contain potentially identifiable information even after de-identification. Only aggregated results will be reported in publications or academic presentations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere